2021
DOI: 10.1016/j.prp.2021.153545
|View full text |Cite
|
Sign up to set email alerts
|

RNF6 promotes colorectal cancer invasion and migration via the Wnt/β-catenin pathway by inhibiting GSK3β activity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(7 citation statements)
references
References 31 publications
1
6
0
Order By: Relevance
“…Furthermore, the overexpression of NSD3 was observed in cancer types including colorectal cancer and it enhances the phosphorylation levels of ERK1/2 in CRC cell lines [ 51 , 52 ]. Last, RNF6 amplification was frequently observed in CRC, linked to cancer progression and metastasis [ 53 , 54 ] as well as an increase in the phosphorylation levels of ERK1 in cervical cancer [ 55 ]. To assess whether the genomic amplification of CCNE1 , NSD3 , RNF6 genes were reflected in increased mRNA expression, we performed real time RT-PCR.…”
Section: Resultsmentioning
confidence: 99%
“…Furthermore, the overexpression of NSD3 was observed in cancer types including colorectal cancer and it enhances the phosphorylation levels of ERK1/2 in CRC cell lines [ 51 , 52 ]. Last, RNF6 amplification was frequently observed in CRC, linked to cancer progression and metastasis [ 53 , 54 ] as well as an increase in the phosphorylation levels of ERK1 in cervical cancer [ 55 ]. To assess whether the genomic amplification of CCNE1 , NSD3 , RNF6 genes were reflected in increased mRNA expression, we performed real time RT-PCR.…”
Section: Resultsmentioning
confidence: 99%
“…7A ). In addition, GSK3β has been found to exhibit a key role in the development of human cancers such as breast cancer, colorectal cancer, and PC [ 31 33 ]. RT-qPCR result showed that GSK3β level was notably downregulated in PC tissues compared to normal tissues (Supplementary Fig.…”
Section: Resultsmentioning
confidence: 99%
“…To verify the above conjecture, we used in this study IM-12, a specific agonist of the Wnt signaling pathway that was reported to specifically inhibit the expression of GSK-3β while increasing the expression of β-catenin and downstream proteins [ 51 , 79 , 80 ]. In this study, it was observed that pre-treatment with CGA partially suppressed the expression of core proteins associated with the Wnt signaling pathway activated by IM-12, such as β-catenin, p-GSK-3β, and c-Myc, while concurrently partially increasing the expression of GSK-3β ( Figure 6 ).…”
Section: Discussionmentioning
confidence: 99%